Bellafill

Energy-Based Treatments Safe After PMMA Injections

Energy-Based Treatments Safe After PMMA Injections

In a recent study, researchers Douglas C. Wu, MD, et al, evaluated the safety and histopathological effects of different laser, light and ultrasound modalities on skin previously injected with a polymethylmethacrylate (PMMA) filler (Bellafill, Suneva Medical).

Bellafill is a soft tissue dermal filler composed of non-resorbable microspheres, suspended in a water-based carrier gel with 3.5% bovine collagen; it is FDA approved for the correction of nasolabial folds and atrophic facial acne scars.

Suneva Medical Closes $25M Investment and Appoints New COO

Suneva Medical announced the closing of a $25 million investment by growth equity firm Essex Woodlands. The new financing will be used to strengthen the company’s growth and the ongoing commercialization of its flagship products: Bellafill, a dermal filler indicated for nasolabial folds and acne scars; and Regenica, a growth factor-based skincare line. In conjunction with the investment, Essex Woodlands will receive one seat on Suneva Medical’s Board of Directors and appoint another independent seat.